55X_ROI_Q1_2026
Nov 17, 9:42 PM
$SLS $330M in capital costs to date.
A nice Tax Write off for
$ABBV . . . . . . . .
$200M Rare Priority Pediatric Review Voucher
Cash on Hand
$277M (post )
$IMGN Raised cash on the back of its P3 in PR/roc
before it was bought for
$10B ....
In May of 2023 / before the Buyout in Dec ////
ImmunoGen Announces Proposed Public Offering of ...
2023-05-03-ImmunoGen-Announces
May 3, 2023 — it intends to offer and sell,
$200 million of shares of its common stock in an underwritten public offering.
https://www.fiercepharma.com/pharma/inside-abbvies-10b-immunogen-buyout-and-bidding-war-it-won
0 replies